Pilot Study to Identify and Validate Digital Biomarkers in Osteoarthritis of the Knee

NCT ID: NCT07031518

Last Updated: 2025-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-14

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To date, treatment options for knee osteoarthritis remain limited, and their clinical evaluation is complex due to the day-to-day fluctuations in symptoms.

Hospital tests provide a point-in-time measurement that is influenced by various factors (fatigue, recent activity, weather, etc.), making reliable assessment difficult. The aim of the study is to assess the feasibility and acceptability of monitoring actual activity using the Syde® portable device in up to 30 subjects. Numerical variables derived from data collected by Syde® will be compared with conventional on-site clinical assessment criteria and with data from healthy participants, in order to identify a reliable and robust metric, thereby improving treatment evaluation and personalised patient management.

MAIN OBJECTIVES

* Evaluate the use of the device
* Identify numerical variables and determine the optimal time window for evaluation

Patients will have two visits: one at inclusion and a second two months later. They will wear Syde® magneto-inertial sensors, one on each ankle, for the month following the initial visit, then a Syde® sensor on the ankle and another on the wrist on the side of the non-dominant hand for the following month. The total duration of the recording period is two months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

SECONDARY OBJECTIVES

* To assess external validity

* Spearman correlation coefficient between variables and WOMAC 3.1 scores
* Spearman correlation coefficient between results and timed tests
* Spearman correlation coefficient between results and Kellgren-Lawrence grade
* Assess ability to discriminate between groups

* Difference between patients and healthy participants, and between the 50% of patients with the lowest WOMAC 3.1 score and the 50% with the highest score, and overlap between groups
* Difference between the three groups of patients according to WOMAC 3.1 score
* Collect qualitative data: Results of qualitative interviews on significant aspects of mobility and device acceptability
* Identify a stiffness index: Ratio between outcome measurements after 0.5 - 1 - 2 or 3 hours of immobility (at least) for 10 minutes and the same outcome measured over the total recording period, excluding the 10-minute intervals.
* Identify the best time of day for recording

* The metric properties of the different variables will be calculated over the time periods 1-11; 1-10; 1-9; 1-8; 1-7; 1-6; 1-5; 1-4; 1-3; 1-2 and the first hour of the day in order to identify whether morning stiffness accentuates the difference between OAK and healthy participants.
* The metric properties of the different variables will be calculated over the time periods 2-12; 3-12; 4-12; 5-12; 6-12; 7-12; 8-12; 9-12; 10-12; 11-12 and 12 hours of the day in order to identify whether evening fatigue accentuates the difference between OAK and healthy participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis of the Knee

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient with osteoarthritis of the knee

Patients will have two visits: one at inclusion and a second two months later. They will wear Syde® magneto-inertial sensors, one on each ankle, for the month following the initial visit, then a Syde® sensor on the ankle and another on the wrist on the side of the non-dominant hand for the following month. The total duration of the recording period is two months.

Group Type ACTIVE_COMPARATOR

Qualitative Interview

Intervention Type OTHER

This interview is designed to better understand the patient's perspective on the impact of osteoarthritis of the knee on their motor function and to inform the selection of digital tools in upcoming clinical studies.

Syde

Intervention Type DEVICE

Actimyo/Syde is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle.

The Self-Paced 40-meter Walk Test (SPWT)

Intervention Type DIAGNOSTIC_TEST

Assesses walking speed over a fixed distance by having participants walk as quickly and safely as possible, but without running, along a 40-meter course.

30-second chair stand test (30s-CST)

Intervention Type DIAGNOSTIC_TEST

It is a simple assessment of lower body strength and endurance. Participants are instructed to stand up and sit down from a chair as many times as possible in 30 seconds.

The Timed up and go test (TUG)

Intervention Type DIAGNOSTIC_TEST

During this standardized test, the subject is observed and timed while he/she rises from a chair, walks 3 meters, performs a 180° turn, walk back toward the chair and sits down.

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC 3.1)

Intervention Type DIAGNOSTIC_TEST

The WOMAC is a widely used self-administered health status measure for evaluating pain, stiffness, and function in patients with osteoarthritis of the hip or knee. The WOMAC measures three separate dimensions: pain (5 questions), stiffness (2 questions) and function (17 questions).

Patient global impression of severity (PGI-S)

Intervention Type DIAGNOSTIC_TEST

The PGI-S is a patient-reported measure that evaluates the perceived severity of a condition based on a standardized scale, ranging from "none" to "very severe".

Pain Level Diary

Intervention Type OTHER

Patients will record their specific OAK average pain level during the day using the VAS scale of 0-10 points for one week at the beginning of each month of recording.

Healthy Subjects

Healthy subjects with similar age and BMI to patients with osteoarthritisof the knee

Group Type ACTIVE_COMPARATOR

Syde

Intervention Type DEVICE

Actimyo/Syde is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle.

The Self-Paced 40-meter Walk Test (SPWT)

Intervention Type DIAGNOSTIC_TEST

Assesses walking speed over a fixed distance by having participants walk as quickly and safely as possible, but without running, along a 40-meter course.

30-second chair stand test (30s-CST)

Intervention Type DIAGNOSTIC_TEST

It is a simple assessment of lower body strength and endurance. Participants are instructed to stand up and sit down from a chair as many times as possible in 30 seconds.

The Timed up and go test (TUG)

Intervention Type DIAGNOSTIC_TEST

During this standardized test, the subject is observed and timed while he/she rises from a chair, walks 3 meters, performs a 180° turn, walk back toward the chair and sits down.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Qualitative Interview

This interview is designed to better understand the patient's perspective on the impact of osteoarthritis of the knee on their motor function and to inform the selection of digital tools in upcoming clinical studies.

Intervention Type OTHER

Syde

Actimyo/Syde is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle.

Intervention Type DEVICE

The Self-Paced 40-meter Walk Test (SPWT)

Assesses walking speed over a fixed distance by having participants walk as quickly and safely as possible, but without running, along a 40-meter course.

Intervention Type DIAGNOSTIC_TEST

30-second chair stand test (30s-CST)

It is a simple assessment of lower body strength and endurance. Participants are instructed to stand up and sit down from a chair as many times as possible in 30 seconds.

Intervention Type DIAGNOSTIC_TEST

The Timed up and go test (TUG)

During this standardized test, the subject is observed and timed while he/she rises from a chair, walks 3 meters, performs a 180° turn, walk back toward the chair and sits down.

Intervention Type DIAGNOSTIC_TEST

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC 3.1)

The WOMAC is a widely used self-administered health status measure for evaluating pain, stiffness, and function in patients with osteoarthritis of the hip or knee. The WOMAC measures three separate dimensions: pain (5 questions), stiffness (2 questions) and function (17 questions).

Intervention Type DIAGNOSTIC_TEST

Patient global impression of severity (PGI-S)

The PGI-S is a patient-reported measure that evaluates the perceived severity of a condition based on a standardized scale, ranging from "none" to "very severe".

Intervention Type DIAGNOSTIC_TEST

Pain Level Diary

Patients will record their specific OAK average pain level during the day using the VAS scale of 0-10 points for one week at the beginning of each month of recording.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with bi- or unilateral Knee Osteoarthritis as confirmed by a qualified rheumatologist/orthopaedist or rehabilitation doctor and having had at least one X-ray or MRI for diagnosis confirmation with Kellgren-Lawrence grade minimum 1
* WOMAC 3.1 total score at screening indicating mild, moderate, or severe symptoms in the past 48 hours
* BMI below 35.0 kg/m2

Exclusion Criteria

* Patients with significant cognitive disorders, limiting the understanding of the exercises to be performed or the presence of apparent communication difficulties hindering the correct collection of data.
* Unable to walk independently (10 meters without any type of external help)
* History of any joint replacement surgery.
* Currently undergoing or had corticosteroid injections within the past 3 weeks.
* Underwent knee surgery in the past 6 months.
* Expecting joint replacement surgery or arthroscopy within 3 months.
* Pregnant women or women planning to become pregnant during the study
* Presence of any other conditions than osteoarthritis (musculoskeletal or neurological) that may affect normal gait. OA in other joints is not considered as an exclusion criterion as long as OAK is the most significant cause of walking impairment.
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Régional de la Citadelle

OTHER

Sponsor Role collaborator

SYSNAV

INDUSTRY

Sponsor Role collaborator

Centre Hospitalier Universitaire de Liege

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Margaux POLEUR

Principal Investigator, Neurologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laurent Servais, MD, PhD

Role: STUDY_DIRECTOR

Centre Hospitalier Universitaire de Liege

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre de référence des maladies neuromusculaire (CRMN Liège), Hopital de la Citadelle

Liège, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Camila Gonzalez-Barral

Role: CONTACT

+3243218222

Nicolas Bovy

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Camila Gonzalez-Barral

Role: primary

Nicolas Bovy

Role: backup

+3243218095

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DigitOAK

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Persona Partial Knee Clinical Outcomes Study
NCT03034811 ACTIVE_NOT_RECRUITING NA
Persona IQ Cohort Study
NCT06089291 ENROLLING_BY_INVITATION
The 3DKnee™ System: A Post-Market Study
NCT00764673 COMPLETED PHASE4
10003 PRO Current Products
NCT01497730 COMPLETED